Ardent Health Partners (ARDT) Competitors $12.57 -0.16 (-1.23%) Closing price 03:59 PM EasternExtended Trading$12.87 +0.30 (+2.39%) As of 05:30 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsTrendsBuy This Stock ARDT vs. HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, CON, and SGRYShould you be buying Ardent Health Partners stock or one of its competitors? The main competitors of Ardent Health Partners include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry. Ardent Health Partners vs. Hims & Hers Health Guardant Health Option Care Health RadNet Sotera Health GeneDx BrightSpring Health Services Privia Health Group Concentra Group Holdings Parent Surgery Partners Hims & Hers Health (NYSE:HIMS) and Ardent Health Partners (NYSE:ARDT) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment. Is HIMS or ARDT more profitable? Hims & Hers Health has a net margin of 8.19% compared to Ardent Health Partners' net margin of 0.00%. Hims & Hers Health's return on equity of 10.97% beat Ardent Health Partners' return on equity.Company Net Margins Return on Equity Return on Assets Hims & Hers Health8.19% 10.97% 8.29% Ardent Health Partners N/A N/A N/A Does the MarketBeat Community favor HIMS or ARDT? Hims & Hers Health received 20 more outperform votes than Ardent Health Partners when rated by MarketBeat users. However, 88.46% of users gave Ardent Health Partners an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote. CompanyUnderperformOutperformHims & Hers HealthOutperform Votes4335.25% Underperform Votes7964.75% Ardent Health PartnersOutperform Votes2388.46% Underperform Votes311.54% Do analysts rate HIMS or ARDT? Hims & Hers Health currently has a consensus price target of $36.92, indicating a potential upside of 5.29%. Ardent Health Partners has a consensus price target of $20.58, indicating a potential upside of 63.67%. Given Ardent Health Partners' stronger consensus rating and higher possible upside, analysts plainly believe Ardent Health Partners is more favorable than Hims & Hers Health.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hims & Hers Health 2 Sell rating(s) 8 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.08Ardent Health Partners 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 2 Strong Buy rating(s) 3.00 Which has stronger earnings and valuation, HIMS or ARDT? Ardent Health Partners has higher revenue and earnings than Hims & Hers Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHims & Hers Health$1.48B5.28-$23.55M$0.5464.93Ardent Health Partners$5.97B0.30$53.90MN/AN/A Does the media prefer HIMS or ARDT? In the previous week, Hims & Hers Health had 41 more articles in the media than Ardent Health Partners. MarketBeat recorded 48 mentions for Hims & Hers Health and 7 mentions for Ardent Health Partners. Ardent Health Partners' average media sentiment score of 1.10 beat Hims & Hers Health's score of 0.64 indicating that Ardent Health Partners is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Hims & Hers Health 20 Very Positive mention(s) 6 Positive mention(s) 12 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Positive Ardent Health Partners 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do insiders and institutionals hold more shares of HIMS or ARDT? 63.5% of Hims & Hers Health shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by insiders. Comparatively, 1.7% of Ardent Health Partners shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. SummaryHims & Hers Health and Ardent Health Partners tied by winning 8 of the 16 factors compared between the two stocks. Get Ardent Health Partners News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDT and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ARDT vs. The Competition Export to ExcelMetricArdent Health PartnersGeneral medical & surgical hospitals IndustryMedical SectorNYSE ExchangeMarket Cap$1.80B$12.88B$5.53B$19.02BDividend YieldN/A0.66%5.11%4.03%P/E RatioN/A5.6022.6533.12Price / Sales0.300.58401.9828.04Price / CashN/A6.8638.1817.52Price / BookN/A32.266.754.51Net Income$53.90M$1.20B$3.22B$1.02B7 Day Performance0.12%3.97%1.66%1.38%1 Month Performance-2.67%0.34%4.17%-1.99%1 Year PerformanceN/A10.88%16.17%5.28% Ardent Health Partners Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ARDTArdent Health Partners2.7484 of 5 stars$12.57-1.2%$20.58+63.7%N/A$1.79B$5.97B0.0024,200Upcoming EarningsAnalyst RevisionPositive NewsHIMSHims & Hers Health2.3685 of 5 stars$28.51+1.5%$38.08+33.6%+164.1%$6.33B$1.48B64.80650Upcoming EarningsAnalyst ForecastInsider TradeOptions VolumeNews CoverageHigh Trading VolumeGHGuardant Health3.9509 of 5 stars$47.99-0.6%$49.00+2.1%+162.4%$5.92B$739.02M-13.481,790Analyst ForecastNews CoverageGap UpOPCHOption Care Health3.8012 of 5 stars$32.97+0.2%$33.75+2.4%+8.1%$5.42B$5.00B27.715,600Earnings ReportAnalyst UpgradeNews CoveragePositive NewsRDNTRadNet4.0206 of 5 stars$51.03+1.5%$69.75+36.7%+8.0%$3.78B$1.83B-728.908,970Positive NewsSHCSotera Health2.3986 of 5 stars$11.26+1.0%$15.20+35.0%+2.7%$3.20B$1.10B45.043,000News CoverageGap UpWGSGeneDx3.7608 of 5 stars$112.49+1.3%$72.33-35.7%+291.6%$3.16B$305.45M-57.391,200Earnings ReportAnalyst ForecastNews CoveragePositive NewsGap UpBTSGBrightSpring Health Services2.5539 of 5 stars$17.31+2.3%$21.67+25.2%+64.0%$3.03B$11.27B-66.5835,000Upcoming EarningsNews CoveragePositive NewsPRVAPrivia Health Group4.1127 of 5 stars$23.20+0.1%$27.14+17.0%+27.6%$2.81B$1.74B232.02810Upcoming EarningsAnalyst ForecastShort Interest ↓News CoveragePositive NewsCONConcentra Group Holdings ParentN/A$21.64+1.8%$28.50+31.7%N/A$2.76B$1.90B14.3311,000Upcoming EarningsPositive NewsSGRYSurgery Partners3.2161 of 5 stars$21.56+0.4%$34.75+61.2%-12.0%$2.75B$3.11B-44.9212,200Upcoming EarningsNews CoveragePositive News Related Companies and Tools Related Companies HIMS Competitors GH Competitors OPCH Competitors RDNT Competitors SHC Competitors WGS Competitors BTSG Competitors PRVA Competitors CON Competitors SGRY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:ARDT) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersBlackrock’s Sending THIS Crypto Higher on PurposeWhile everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | SponsoredHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredTrump announcement boosts “next Bitcoin”President Trump just made his first big crypto move ... Announcing the creation of a national strategic re...Weiss Ratings | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardent Health Partners, LLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardent Health Partners With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.